362 related articles for article (PubMed ID: 25149979)
1. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.
Sobczak M; Fabisiak A; Murawska N; Wesołowska E; Wierzbicka P; Wlazłowski M; Wójcikowska M; Zatorski H; Zwolińska M; Fichna J
Pharmacol Rep; 2014 Oct; 66(5):766-75. PubMed ID: 25149979
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery strategies in the therapy of inflammatory bowel disease.
Lautenschläger C; Schmidt C; Fischer D; Stallmach A
Adv Drug Deliv Rev; 2014 May; 71():58-76. PubMed ID: 24157534
[TBL] [Abstract][Full Text] [Related]
3. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
4. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
[TBL] [Abstract][Full Text] [Related]
5. Current therapy of inflammatory bowel disease in children.
Rufo PA; Bousvaros A
Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
[TBL] [Abstract][Full Text] [Related]
6. Conventional drug therapy for inflammatory bowel disease.
Bryant RV; Brain O; Travis SP
Scand J Gastroenterol; 2015 Jan; 50(1):90-112. PubMed ID: 25523560
[TBL] [Abstract][Full Text] [Related]
7. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.
Stefanelli T; Malesci A; Repici A; Vetrano S; Danese S
Curr Drug Targets; 2008 May; 9(5):413-8. PubMed ID: 18473770
[TBL] [Abstract][Full Text] [Related]
8. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
9. Current therapeutic approaches in inflammatory bowel disease.
Sohrabpour AA; Malekzadeh R; Keshavarzian A
Curr Pharm Des; 2010; 16(33):3668-83. PubMed ID: 21128898
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.
de Mattos BR; Garcia MP; Nogueira JB; Paiatto LN; Albuquerque CG; Souza CL; Fernandes LG; Tamashiro WM; Simioni PU
Mediators Inflamm; 2015; 2015():493012. PubMed ID: 26339135
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Diseases of the Gut.
Rohr M; Narasimhulu CA; Sharma D; Doomra M; Riad A; Naser S; Parthasarathy S
J Med Food; 2018 Feb; 21(2):113-126. PubMed ID: 29389238
[TBL] [Abstract][Full Text] [Related]
12. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
Hanauer SB; Stathopoulos G
Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
[TBL] [Abstract][Full Text] [Related]
13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of IBD associated diarrhea.
Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.
Barros LL; Farias AQ; Rezaie A
World J Gastroenterol; 2019 Aug; 25(31):4414-4426. PubMed ID: 31496621
[TBL] [Abstract][Full Text] [Related]
16. The Complex Interplay Between Inflammatory Bowel Disease and Malignancy.
Kimmel J; Axelrad J
Curr Gastroenterol Rep; 2020 Feb; 22(3):13. PubMed ID: 32056030
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
Yang C; Merlin D
Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
[TBL] [Abstract][Full Text] [Related]
18. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Ochsenkühn T; Sackmann M; Göke B
Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of inflammatory bowel disease in children.
Oliveira SB; Monteiro IM
BMJ; 2017 May; 357():j2083. PubMed ID: 28566467
[TBL] [Abstract][Full Text] [Related]
20. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.
Degasperi E; Caprioli F; El Sherif O; Back D; Colombo M; Aghemo A
Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1373-1383. PubMed ID: 27718758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
